The recent analytical report published by Markntel Advisors (a leading consulting, data analytics, and market research firm), Autoimmune Disorder Drug Delivery Devices Market comprises a detailed study of critical and major aspects of market dynamics, i.e. market trends, size, forecasts, growth factors, challenges, and competitor landscape. The research company provides an extensive range of strategic reports on diverse industry verticals to substantial and varied client bases, including multinational corporations, financial institutions, governments, and individuals, among others.
Autoimmune Disorder Drug Delivery Devices Industry Analytical Overview (2022-2027): Drivers, Opportunities, Challenges, and Trends,
According to the latest report, Autoimmune Disorder Drug Delivery Devices Market is projected to grow at a CAGR of around 16.89% in terms of revenue during the forecast period, i.e., 2022-27. The report significantly addressed considerable changes, gap analyses, and competitive studies using qualitative and quantitative data. These include the widespread segmentation, geography, and recent developments, entailing information on the fluctuation in the demand, sales, revenue, and other parameters experienced and expected in the industry for the forecasting year i.e. 2022 to 2027.
In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Download Report Sample PDF – https://www.marknteladvisors.com/query/request-sample/global-autoimmune-disorder-drug-delivery-devices-market.html
What is Included in Autoimmune Disorder Drug Delivery Devices Market Segmentation?
The report has segmented the market into the following categories:
By Product Type
- Prefilled Syringes
-
Auto-injectors
-
Infusion pumps
-
Nebulizers
-
Nasal sprays
-
Others (Eyedropper, Transdermal patches, etc.)
Among them, Prefilled Syringes hold a prominent share in the market, owing to the rising demand for convenient & safe-filled syringes over conventional glass vials for parental drug packing. Moreover, a growing number of biosimilars & biologics in the market are supporting the growth of prefilled syringes across the world. In addition, technological advancements, rising adoption of self-injecting parenteral devices, and supportive government regulations are propelling the growth of prefilled syringes for autoimmune disorders.
By Indication
- Psoriasis
-
Rheumatoid Arthritis
-
Multiple Sclerosis
-
Inflammatory Bowel Diseases
-
Systemic Lupus Erythematosus
-
Diabetes Mellitus
-
Others (Guillain Barre Syndrome, Grave’s Disease, etc.)
By Manufacturing Type
- In-House Manufacturing
– Outsourced Manufacturing
By End User
- Hospitals
-
Diagnostic centres
-
Ambulatory surgery centres
-
Others (Clinics, Home care settings, etc.)
By Region
- North America
-
South America
-
Europe
-
Middle East & Africa
-
Asia-Pacific
(“Kindly use your official email ID for all correspondence to ensure seamless engagement and access to exclusive benefits, along with prioritized support from our sales team.”)
Access the Complete Report for An In-Depth Analysis – https://www.marknteladvisors.com/research-library/global-autoimmune-disorder-drug-delivery-devices-market.html
Key Factor Driver Autoimmune Disorder Drug Delivery Devices Industry Growth by 2027
A significant increase in the adoption of self-injectable devices for the treatment of autoimmunity disorders such as diabetes etc., combined with the rapid surge in hospital-acquired infections, high medical costs, and longer wait hauls, have accelerated the shift towards the use of autoimmune disorder drug delivery devices in households globally. Moreover, various companies such as Becton, Dickinson, and Insulet Corporation have launched self-injectable devices to bring economic benefits to both patients & healthcare systems. For instance, pressure-assisted auto-injectors by Antares Pharma are a form of parenteral drug delivery to address acute & chronic medical needs such as rheumatoid arthritis, allergic reactions, psoriasis, and other therapies.
Who are the Key Players Operating in the Autoimmune Disorder Drug Delivery Devices Industry?
The top companies of the Autoimmune Disorder Drug Delivery Devices market ruling the industry are:
- Amgen Inc.
- AbbVie Inc.
- Bayer AG
- Biogen Inc.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche AG
- GlaxoSmithKline plc
- Johnson & Johnson Services, Inc.
- The Merck Group
- Novartis International AG
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- UCB Pharma SA.
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
Click Here to Connect with Our Expertise – https://www.marknteladvisors.com/query/talk-to-our-consultant/global-autoimmune-disorder-drug-delivery-devices-market.html
Key Objectives of Choosing Markntel Advisor’s Report
- Focused Industry Expertise
- Diverse Report Offerings
- Personalized Research Solutions
- Robust Research Methodology
- In-depth Report Coverage
- Tracking Technological Advancements
- Comprehensive Value-Chain Analysis
- Discovering Market Opportunities
- Analysing Growth Trajectories
- Assured Quality Insights
- Dedicated After-Sales Support
FAQs (Frequently Ask Questions)
- What are the industry’s overall statistics or estimates including CARG and USD Value of the forecasting years?
- What are the trends influencing the current scenario of the Autoimmune Disorder Drug Delivery Devices Market?
- What are the key factors that would propel and hinder the industry?
- Which geographical area dominates the Autoimmune Disorder Drug Delivery Devices industry?
- Which is the Leading segment in the market?
About US:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
For Media Inquiries, Please Contact:
Phone: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
